U.S.-China Trade Tensions Threaten Biotech Cash Surge

(Bloomberg) -- Increasing wariness in Washington over China’s investments in U.S. biotechnology companies may cool a hot source of capital for medical startups.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.